Navigation Links
Hadasit Bio-Holdings CEO Letter to Shareholders
Date:4/9/2013

s conditionally based on initially investing a relatively small amount of capital in order to finance a feasibility trial with one of Hadassah's specialists, while having the option of investing significantly after the initial trial if successful. We are also looking into the possibility of diversifying our portfolio by adding companies that develop  products which require less regulation and present a shorter time to market, such as medical devices and medical IT – fields in which Hadassah is already an established world leader.

In summary, we feel that our maturing portfolio, unique list of valuable assets, proven expertise in numerous fields of science, and experienced and hands-on management, coupled with an attractive share price and substantial growth potential for the Israeli biotechnology industry – all make HBL a highly attractive investment opportunity. Furthermore, the fact that an investment in the Company would directly help progress the research and development of innovative medical treatments with the potential to save thousands or even millions of lives from all over the world make it not only rewarding financially, but important in many other ways.

We remain confident in our assertion that 2013 promises to be a noteworthy year for HBL and its investors. We are immensely proud to have your confidence as shareholders, potential investors and partners for success. Your continued support and involvement only validates and affirms our corporate mission; to not only be a success financially, but to succeed in providing innovative medical treatments for the betterment of mankind.

About Hadasit Bio-Holdings

Hadasit Bio-Holdings, Ltd., established in 2006, is the publicly traded subsidiary of Hadasit Ltd. - the technology transfer company of the Hadassah University Hospital, Israel's foremost medical research center. The Company was established for the purpose of promoting and commercial
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
5. NeoStems CEO Letter to Shareholders
6. Genesis Biopharma Issues Letter To Shareholders
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Ronald L. Chez Files Amended 13D and Letter to the Board
10. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
11. Amarantus BioSciences Issues CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus ... and clinical safety assessment in biosimilars. , Regulatory ... path for biosimilar drug development, however the complex ... with regards to quality, safety and efficacy extremely ... drug development and registration, development strategies differ significantly ...
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... for Life Science organizations who need document translations. ... subject matter of their documents in advance with a ... help reduce time-to-delivery of translations, often a critical factor ... of error. , “All translations are inherently time-sensitive by ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, ... Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... only national nonprofit organization solely dedicated to finding a ... life for those affected worldwide, will host its annual ... Club in Warrington, Pa. , Each year, the ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Borough ... Challenge. , ... (Vocus) March 12, 2010 -- Borough of Manhattan Community College (BMCC) science major ... Science Challenge—as well as $5,000 as an overall Grand Prizewinner., , , , ,Thompson--the contest,s ...
... ... , ... ... SEATTLE, WA , March 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that it will restate its ...
... , THOUSAND OAKS, Calif. , March 11 Bone Biologics, Inc. announced today that it has received a US Patent Office Notice ... of the NELL 1 (UCB-1) protein by several delivery agents. , ... , ... ...
Cached Biology Technology:BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 4Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 5Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 6Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 7Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 8Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 9Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 10Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3
(Date:4/15/2014)... for nearly all life on Earth, yet many aspects ... is known about how it is regulated in response ... not know the full list of the parts of ... , , A type of single-cell green algae called ... photosynthesis research. Despite its importance in the research world, ...
(Date:4/15/2014)... early as 2020 how high sea levels will rise ... researchers including Florida International University scientist Rene Price. , ... (NSF) Florida Coastal Everglades Long-Term Ecological Research (LTER) site, ... from coral reefs to deserts, mountains to salt marshes ... rise is one of the most certain consequences of ...
(Date:4/15/2014)... previously shown that a genetic pre-disposition to be more ... study, Frank Booth, a professor in the MU College ... the genetic pre-disposition for high levels of exercise motivation ... For his study, Booth selectively bred rats that exhibited ... then put the rats in cages with running wheels ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Genetic pre-disposition toward exercise and mental development may be linked 2
... between a gene involved in vitamin D metabolism and skin ... CANCER , a peer-reviewed journal of the American Cancer Society, ... vitamin D-related gene, called BsmI, may be at an increased ... D in the body has significant protective effects against the ...
... of Minnesota College of Veterinary Medicine have identified a gene ... exercise-induced collapse (EIC). After intense hunting or retrieving exercise, activities ... lose control of their hind limbs. In most cases, ... in rare cases the dogs may die. Labradors are ...
... Two professors at Cold Spring Harbor Laboratory (CSHL) have ... of proteins that enable genes to express themselves in ... Michael Q. Zhang, Ph.D. and Adrian R. Krainer, ... are exploring a phenomenon that biologists and geneticists call ...
Cached Biology News:Variant of vitamin D receptor gene linked to melanoma risk 2U of M researchers identify gene linked to common ailment in labrador retrievers 2CSHL team traces extensive networks regulating alternative RNA splicing 2CSHL team traces extensive networks regulating alternative RNA splicing 3CSHL team traces extensive networks regulating alternative RNA splicing 4
... analysis software with the DeCypher Engine accelerator cards ... can perform searches like these from your desktop: ... in under 6 days Align BAC-sized ... Use HMM analysis to compare 100,000 sequences to ...
Mouse monoclonal antibody to FMN2 - formin 2...
Rabbit polyclonal to SMARCA2 / BRM - ChIP Grade ( Abpromise for all tested applications). entrezGeneID: 6595 SwissProtID: P51531...
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
Biology Products: